F. Massicot

发表

Design of Group IIA Secreted/Synovial Phospholipase A2 Inhibitors: An Oxadiazolone Derivative Suppresses Chondrocyte Prostaglandin E2 Secretion

N. Gresh, C. Dong, J. Ombetta, 2010, PloS one.

Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.

M. Port, P. Bruneval, C. Mandet, 2013, Toxicological sciences : an official journal of the Society of Toxicology.

Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide

M. Port, P. Bruneval, C. Mandet, 2012, British journal of pharmacology.

Aryl hydrocarbon receptor upregulates IL-1β expression in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure.

X. Coumoul, R. Bendayan, X. Declèves, 2017, Toxicology in vitro : an international journal published in association with BIBRA.

Effects of cyclosporin on kidney glutathione metabolism and cytochrome P-450 in the rabbit: possible implication of eicosanoid metabolism.

C. Martin, J. Warnet, M. Thévenin, 1994, Drug and chemical toxicology.

Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects

F. Woimant, J. Trocello, J. Poupon, 2009, Analytical and bioanalytical chemistry.

Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis.

F. Woimant, P. Chappuis, J. Trocello, 2011, Clinica chimica acta; international journal of clinical chemistry.

Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model

D. Dargère, O. Laprévote, A. Regazzetti, 2012, Analytical and Bioanalytical Chemistry.

In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin.

H. Duc, C. Pham-Huy, Xu-hui Liu, 2005, Basic & clinical pharmacology & toxicology.

Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.

C. Dong, C. Redeuilh, J. Huet, 2005, Bioorganic & medicinal chemistry.

Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives.

G. Dive, C. Redeuilh, A. Lamouri, 2010, Bioorganic & medicinal chemistry.

Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line

C. Pham-Huy, J. Warnet, M. Thévenin, 1997, Archives of Toxicology.

Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK1 oxidative injury.

A. Lamouri, C. Pham-Huy, F. Heymans, 1997, Journal of lipid mediators and cell signalling.

Inhibitory effects of a platelet activating factor-antagonist 48740RP in cyclosporin-induced nephrotoxicity in the rat as assessed by renal glutathione metabolism parameters.

C. Martin, J. Warnet, M. Thévenin, 1991, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.

Zhenguo Liu, C. Dong, J. Ombetta, 2006, Toxicology in vitro : an international journal published in association with BIBRA.

Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.

C. Broquet, J. Haelters, J. Godfroid, 1991, Journal of lipid mediators.

Pharmacokinetic profiles of methadone enantiomers and its major metabolite in serum, saliva and urine of treated patients

C. Pham-Huy, H. Galons, J. Warnet, 1998 .

Enantioselective high-performance liquid chromatography determination of methadone enantiomers and its major metabolite in human biological fluids using a new derivatized cyclodextrin-bonded phase.

C. Pham-Huy, H. Galons, J. Warnet, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells.

J. Ombetta, J. Warnet, H. Dutertre-Catella, 2008, Neurotoxicology.

Amyloid β Peptide Induces Apoptosis Through P2X7 Cell Death Receptor in Retinal Cells: Modulation by Marine Omega-3 Fatty Acid DHA and EPA

G. A. Limb, F. Mascarelli, M. Dutot, 2015, Applied Biochemistry and Biotechnology.

Effects of 24R,25-dihydroxyvitamin D3 on alkaline phosphatase activity in pig renal epithelial LLC-PK1 cells in culture.

J. Warnet, J. Claude, N. Taniguchi, 1998, General pharmacology.

Structure-activity relationships in platelet-activating factor (PAF). 8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: anti-acetylcholinesterase activity and comparative SAR.

N. Blavet, J. Godfroid, L. Texier, 1996, Journal of lipid mediators and cell signalling.

A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine.

Zhenguo Liu, C. Dong, J. Ombetta, 2007, International immunopharmacology.

Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.

G. Lambeau, C. Dong, C. Redeuilh, 2007, Journal of medicinal chemistry.

Inhibition of secretory phospholipase A2. 1-design, synthesis and structure-activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s.

C. Mounier, C. Dong, A. Lamouri, 2005, European journal of medicinal chemistry.

AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival.

F. Mascarelli, A. Faussat, M. Dutot, 2018, Current Alzheimer research.

P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach

P. Rat, O. Laprévote, F. Coudoré, 2013, PloS one.

Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice

B. Palmier, J. Warnet, F. Noble, 2007, Neuroscience Letters.

1α,25-dihydroxyvitamin D3 stimulated alkaline phosphatase activity in cultured pig kidney epithelial LLC-PK1 cells

J. Claude, F. Massicot, D. Durand, 1996 .

Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection.

F. Woimant, J. Trocello, J. Poupon, 2010, Analytical chemistry.

Analysis of (S)- and (R)-propranolol in human plasma and urine by a specific immunoenzymatic assay versus HPLC

H. Duc, H. Galons, J. Warnet, 1994 .

Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice.

C. Dong, Hong-Zhuan Chen, Z. Xia, 2009, The international journal of neuropsychopharmacology.

Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells

C. Dong, Hong-Zhuan Chen, J. Ombetta, 2005, Neuroscience Letters.

Effects of a new anorectic drug (PM 170) on development of gold thioglucose-induced obesity in mice.

F. Heymans, J. Godfroid, M. Apfelbaum, 1987, General pharmacology.

Is quantitative sensory testing helpful in the management of oxaliplatin neuropathy? a two-year clinical study.

O. Laprévote, N. Auzeil, H. Beaussier, 2018, Cancer treatment and research communications.

Analysis of (S)- and (R)-propranolol in human plasma and urine by a specific immunoenzymatic assay versus HPLC.

H. Duc, C. Pham-Huy, H. Galons, 1995, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.

C. Dong, Hong-Zhuan Chen, F. Heymans, 2007, The international journal of neuropsychopharmacology.